LATS2 and neoplasm: Moreover, immunohistochemical analysis suggested that the slower tumor growth rate and the reduced metastasis by miR-25 inhibition were, at least in part, due to the upregulation of LATS2 and E-cadherin expression and the downregulation of Vimentin and MMP9.